1-6 of 6
Omid Tavana
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and characterization of a potent and selective BLIMP1 protac as a novel, first-in-class therapy for multiple myeloma

Free
Minhui Shen, Ankit Sharma, Courtney Andersen, Jennifer Nelson, Judit Debreczeni, Paige Hauke, Michelle Wu, Yuhan Huang, Keith Dillman, Huiling Liang, Zhan Liu, Collin Tokheim, Alex Seong, Lori Chan, Kevin Moreau, Uthpala Seneviratne, Meha Singh, Taylor Quinn, Lucas Morrill, Rick Davies, Pablo Gutierrez, Abhishek Srivastava, Dimitrios Voulgarelis, Michelle Lamb, Jamal Saeh, Anas Younes, David Wilson, Stephen Fawell, Lisa Drew, Omid Tavana
Journal: Blood
Blood (2025) 146 (Supplement 1): 2554.
https://doi.org/10.1182/blood-2025-2554
Published: 2025
Journal Articles

The effects of bruton tyrosine kinase inhibitors on the waldenstrom macroglobulinemia microenvironment

Free
Stephen Blackmore, Rachel Zawacki, Collin Tokheim, Lisa Drew, Omid Tavana, Sherine Elsawa
Journal: Blood
Blood (2025) 146 (Supplement 1): 1786.
https://doi.org/10.1182/blood-2025-1786
Published: 2025
Journal Articles

Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1 -mutant AML

Free
Aristi Damaskou, Rachael Wilson, Malgorzata Gozdecka, George Giotopoulos, Ryan Asby, Maria Eleftheriou, Muxin Gu, Christian Récher, Véronique Mansat-De Mas, Francois Vergez, Ambrine Sahal, Binje Vick, Evangelia K. Papachristou, Ashley Sawle, Eliza Yankova, Monika Dudek, Xiaoxuan Liu, James Russell, Justyna Rak, Christine Hilcenko, Clive D’Santos, Irmela Jeremias, Jean-Emmanuel Sarry, Konstantinos Tzelepis, Brian J. P. Huntly, Alan J. Warren, Omid Tavana, George S. Vassiliou
Journal: Blood
Blood (2025) 146 (10): 1239–1252.
https://doi.org/10.1182/blood.2024026113
Published: 2025
Includes: Supplemental data
Journal Articles

Discovery of UBE2B and RNF144b As Potential Candidates for Selective Degradation of NPM1c in AML

Free
Neeraj K Aryal, Thomas Frost, Yuhan Huang, Bo Kyung Alex Seong, Lisa Drew, Omid Tavana
Journal: Blood
Blood (2024) 144 (Supplement 1): 4969.
https://doi.org/10.1182/blood-2024-208385
Published: 2024
Journal Articles

Establishing an AML Ex Vivo Platform to Generate Physiologically Relevant Models

Free
Omid Tavana, Brandon Willis, Siyu Liu, Amanda Christie, Courtney L Andersen, Justine Roderick-Richardson, Amanda Robichaud, Laura Prickett, Corinne Reimer, Lisa Drew
Journal: Blood
Blood (2023) 142 (Supplement 1): 7136.
https://doi.org/10.1182/blood-2023-177856
Published: 2023
Journal Articles

Combination of AZD4573, a Selective CDK9 Inhibitor, with Other Cell Death Inducing Agents Can Overcome De Novo Venetoclax Resistance in Preclinical Hematologic Tumor Models

Free
Justin Cidado, PhD, Scott Boiko, MS, Theresa Proia, PhD, Haley Woods, MS, Omid Tavana, PhD, Maryann San Martin, MS, Adriana E. Tron, PhD, Wenlin Shao, PhD, Lisa Drew, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3946.
https://doi.org/10.1182/blood-2018-99-113423
Published: 2018